Literature DB >> 2173762

Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins.

T J French1, J J Marshall, P Roy.   

Abstract

Bluetongue is a disease of ruminants. The etiologic agent is bluetongue virus (BTV), a gnat-transmitted member of the Orbivirus genus of the Reoviridae. The virus has a genome of 10 double-stranded RNA species L1 to L3, M4 to M6, S7 to S10). The L2 and M5 genes of BTV which encode the outer capsid proteins VP2 and VP5, respectively, were inserted into a recombinant baculovirus downstream of duplicated copies of the baculovirus polyhedrin promoter. Insect cells coinfected with this virus plus a recombinant baculovirus expressing the two major core proteins VP3 and VP7 of BTV (T.J. French and P. Roy, J. Virol. 64:1530-1536, 1990) synthesized noninfectious, double-shelled, viruslike particles. When purified, these particles were found to have the same size and appearance as authentic BTV virions and exhibited high levels of hemagglutination activity. Antibodies raised to the expressed particles contained high titers of neutralizing activity against the homologous BTV serotype. The assembly of these bluetongue viruslike particles after the simultaneous expression of four separate proteins is indicative of the potential of this technology for the production of a new generation of viral vaccines and for the study of complex, multiprotein structures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173762      PMCID: PMC248707          DOI: 10.1128/JVI.64.12.5695-5700.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Complete sequence of bluetongue virus L2 RNA that codes for the antigen recognized by neutralizing antibodies.

Authors:  M A Purdy; H Ghiasi; C D Rao; P Roy
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

2.  Nucleotide sequence of cDNA clones encoding the outer capsid protein, VP5, of bluetongue virus serotype 10.

Authors:  M A Purdy; G D Ritter; P Roy
Journal:  J Gen Virol       Date:  1986-05       Impact factor: 3.891

3.  Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep.

Authors:  H Huismans; N T van der Walt; M Cloete; B J Erasmus
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

4.  The development of multiple expression vectors for high level synthesis of eukaryotic proteins: expression of LCMV-N and AcNPV polyhedrin protein by a recombinant baculovirus.

Authors:  V C Emery; D H Bishop
Journal:  Protein Eng       Date:  1987 Aug-Sep

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Genetic reassortants for identification of the genome segment coding for the bluetongue virus hemagglutinin.

Authors:  J A Cowley; B M Gorman
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Co-expression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors.

Authors:  K Takehara; D Ireland; D H Bishop
Journal:  J Gen Virol       Date:  1988-11       Impact factor: 3.891

8.  High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection.

Authors:  J J Marshall; P Roy
Journal:  Virus Res       Date:  1990-03       Impact factor: 3.303

9.  A haemagglutination and haemagglutination inhibition test for bluetongue virus.

Authors:  N T van der Walt
Journal:  Onderstepoort J Vet Res       Date:  1980-06       Impact factor: 1.792

10.  Identification of the serotype-specific and group-specific antigens of bluetongue virus.

Authors:  H Huismans; B J Erasmus
Journal:  Onderstepoort J Vet Res       Date:  1981-06       Impact factor: 1.792

View more
  44 in total

1.  Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses.

Authors:  G Tosser; M Labbé; M Brémont; J Cohen
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins.

Authors:  M Sabara; M Parker; P Aha; C Cosco; E Gibbons; S Parsons; L A Babiuk
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 3.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

4.  Baculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection.

Authors:  L D Jones; T Williams; D Bishop; P Roy
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5.  Meeting report VLPNPV: Session 5: Plant based technology.

Authors:  Lydia R Meador; Tsafrir S Mor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins.

Authors:  D R Thomsen; L L Roof; F L Homa
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

7.  Assembly and intracellular localization of the bluetongue virus core protein VP3.

Authors:  Alak Kanti Kar; Nao Iwatani; Polly Roy
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.

Authors:  A K Basak; P Gouet; J Grimes; P Roy; D Stuart
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1.

Authors:  L Montross; S Watkins; R B Moreland; H Mamon; D L Caspar; R L Garcea
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA.

Authors:  Rob J Noad; Meredith Stewart; Mark Boyce; Cristina C Celma; Keith R Willison; Polly Roy
Journal:  BMC Mol Biol       Date:  2009-09-02       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.